Sex, tissue, and mitochondrial interactions modify the transcriptional response to rapamycin in Drosophila.

Autor: Raynes Y; Department of Ecology, Evolution, and Organismal Biology, Brown University, Providence, RI, 02912, USA. yevgeniy_raynes@brown.edu.; Center for Computational Molecular Biology, Brown University, Providence, RI, 02912, USA. yevgeniy_raynes@brown.edu., Santiago JC; Department of Molecular Biology, Cellular Biology and Biochemistry, Brown University, Providence, RI, 02912, USA., Lemieux FA; Department of Ecology, Evolution, and Organismal Biology, Brown University, Providence, RI, 02912, USA., Darwin L; Department of Ecology, Evolution, and Organismal Biology, Brown University, Providence, RI, 02912, USA.; Center for Computational Molecular Biology, Brown University, Providence, RI, 02912, USA., Rand DM; Department of Ecology, Evolution, and Organismal Biology, Brown University, Providence, RI, 02912, USA. david_rand@brown.edu.; Center for Computational Molecular Biology, Brown University, Providence, RI, 02912, USA. david_rand@brown.edu.
Jazyk: angličtina
Zdroj: BMC genomics [BMC Genomics] 2024 Aug 07; Vol. 25 (1), pp. 766. Date of Electronic Publication: 2024 Aug 07.
DOI: 10.1186/s12864-024-10647-x
Abstrakt: Background: Many common diseases exhibit uncontrolled mTOR signaling, prompting considerable interest in the therapeutic potential of mTOR inhibitors, such as rapamycin, to treat a range of conditions, including cancer, aging-related pathologies, and neurological disorders. Despite encouraging preclinical results, the success of mTOR interventions in the clinic has been limited by off-target side effects and dose-limiting toxicities. Improving clinical efficacy and mitigating side effects require a better understanding of the influence of key clinical factors, such as sex, tissue, and genomic background, on the outcomes of mTOR-targeting therapies.
Results: We assayed gene expression with and without rapamycin exposure across three distinct body parts (head, thorax, abdomen) of D. melanogaster flies, bearing either their native melanogaster mitochondrial genome or the mitochondrial genome from a related species, D. simulans. The fully factorial RNA-seq study design revealed a large number of genes that responded to the rapamycin treatment in a sex-dependent and tissue-dependent manner, and relatively few genes with the transcriptional response to rapamycin affected by the mitochondrial background. Reanalysis of an earlier study confirmed that mitochondria can have a temporal influence on rapamycin response.
Conclusions: We found significant and wide-ranging effects of sex and body part, alongside a subtle, potentially time-dependent, influence of mitochondria on the transcriptional response to rapamycin. Our findings suggest a number of pathways that could be crucial for predicting potential side effects of mTOR inhibition in a particular sex or tissue. Further studies of the temporal response to rapamycin are necessary to elucidate the effects of the mitochondrial background on mTOR and its inhibition.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: